| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.816 | 0.009 | 0.843 | Caspase 9 stimulant | 0.716 0.022 DBMET02756 0.798 0.011 DBMET02757 0.843 0.006 DB15534 | DB15534 | |
| 0.793 | 0.004 | 0.795 | Tubulin antagonist | 0.703 0.004 DBMET02756 0.795 0.004 DBMET02757 0.776 0.004 DB15534 | DBMET02757 | |
| 0.671 | 0.003 | 0.708 | Beta tubulin antagonist | 0.684 0.003 DBMET02756 0.708 0.003 DBMET02757 0.667 0.003 DB15534 | DBMET02757 | |
| 0.597 | 0.003 | 0.621 | Alpha tubulin antagonist | 0.351 0.004 DBMET02756 0.486 0.004 DBMET02757 0.621 0.003 DB15534 | DB15534 | |
| 0.552 | 0.009 | 0.552 | Antimitotic | 0.363 0.03 DBMET02756 0.453 0.017 DBMET02757 0.54 0.01 DB15534 | ||
| 0.583 | 0.053 | 0.617 | Apoptosis agonist | 0.462 0.087 DBMET02756 0.49 0.077 DBMET02757 0.617 0.045 DB15534 | DB15534 | |
| 0.453 | 0.029 | 0.477 | Caspase 3 stimulant | 0.425 0.037 DBMET02756 0.457 0.028 DBMET02757 0.477 0.024 DB15534 | DB15534 | |
| 0.435 | 0.045 | 0.465 | Vasodilator, peripheral | 0.308 0.093 DBMET02756 0.404 0.054 DBMET02757 0.465 0.036 DB15534 | DB15534 | |
| 0.395 | 0.041 | 0.462 | Spasmolytic | 0.187 0.131 DBMET02756 0.282 0.077 DBMET02757 0.462 0.029 DB15534 | DB15534 | |
| 0.349 | 0.002 | 0.426 | Topoisomerase II beta inhibitor | 0.255 0.003 DBMET02756 0.273 0.003 DBMET02757 0.426 0.002 DB15534 | DB15534 | |
| 0.398 | 0.079 | 0.398 | 5 Hydroxytryptamine release inhibitor | 0.398 0.079 DBMET02756 0.364 0.104 DBMET02757 0.368 0.101 DB15534 | ||
| 0.362 | 0.047 | 0.447 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.211 0.094 DBMET02756 0.221 0.089 DBMET02757 0.447 0.028 DB15534 | DB15534 | |
| 0.305 | 0.017 | 0.335 | Topoisomerase II inhibitor | 0.333 0.015 DBMET02756 0.268 0.022 DBMET02757 0.335 0.014 DB15534 | DB15534 | |
| 0.326 | 0.048 | 0.358 | DNA damaging | 0.293 0.06 DBMET02756 0.285 0.063 DBMET02757 0.358 0.038 DB15534 | DB15534 | |
| 0.315 | 0.046 | 0.342 | Transcription factor STAT3 inhibitor | 0.223 0.108 DBMET02756 0.221 0.11 DBMET02757 0.342 0.036 DB15534 | DB15534 | |
| 0.3 | 0.053 | 0.308 | Tumour necrosis factor alpha release inhibitor | 0.189 0.118 DBMET02756 0.196 0.112 DBMET02757 0.308 0.05 DB15534 | DB15534 | |
| 0.327 | 0.084 | 0.446 | Transcription factor NF kappa B inhibitor | 0.35 0.077 DBMET02756 0.372 0.07 DBMET02757 0.446 0.054 DB15534 | DB15534 | |
| 0.249 | 0.01 | 0.272 | Topoisomerase II alpha inhibitor | 0.253 0.01 DBMET02756 0.199 0.015 DBMET02757 0.272 0.009 DB15534 | DB15534 | |
| 0.3 | 0.079 | 0.327 | Sodium/bile acid cotransporter inhibitor | 0.319 0.062 DBMET02756 0.327 0.056 DBMET02757 0.323 0.059 DB15534 | DBMET02757 | |
| 0.275 | 0.06 | 0.386 | Antiamyloidogenic | 0.218 0.088 DBMET02756 0.209 0.094 DBMET02757 0.386 0.031 DB15534 | DB15534 | |
| 0.248 | 0.042 | 0.248 | P-glycoprotein inhibitor | 0.191 0.07 DBMET02756 0.217 0.054 DBMET02757 0.243 0.044 DB15534 | ||
| 0.235 | 0.033 | 0.325 | Amylase inhibitor | 0.312 0.017 DBMET02756 0.292 0.019 DBMET02757 0.325 0.015 DB15534 | DB15534 | |
| 0.232 | 0.035 | 0.232 | 3C-like protease (Human coronavirus) inhibitor | 0.158 0.088 DB15534 | ||
| 0.212 | 0.03 | 0.212 | Acetylcholinesterase inhibitor | 0.124 0.075 DBMET02756 0.133 0.067 DBMET02757 0.196 0.034 DB15534 | ||
| 0.251 | 0.074 | 0.251 | 5 Hydroxytryptamine 1E antagonist | 0.234 0.093 DB15534 | ||
| 0.317 | 0.143 | 0.358 | Calcium channel L-type activator | 0.358 0.111 DBMET02756 0.339 0.126 DBMET02757 0.349 0.118 DB15534 | DBMET02756 | |
| 0.256 | 0.083 | 0.285 | Transcription factor STAT inhibitor | 0.285 0.065 DB15534 | DB15534 | |
| 0.277 | 0.105 | 0.277 | Angiogenesis inhibitor | 0.264 0.113 DB15534 | ||
| 0.195 | 0.025 | 0.195 | Alpha 2b adrenoreceptor antagonist | 0.172 0.031 DB15534 | ||
| 0.191 | 0.022 | 0.204 | Microtubule formation inhibitor | 0.148 0.038 DBMET02756 0.168 0.029 DBMET02757 0.204 0.019 DB15534 | DB15534 | |
| 0.221 | 0.057 | 0.271 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.264 0.037 DBMET02756 0.252 0.042 DBMET02757 0.271 0.034 DB15534 | DB15534 | |
| 0.244 | 0.083 | 0.264 | Interleukin agonist | 0.264 0.069 DB15534 | DB15534 | |
| 0.189 | 0.029 | 0.234 | Toll-Like receptor 2 antagonist | 0.19 0.029 DBMET02756 0.199 0.024 DBMET02757 0.234 0.012 DB15534 | DB15534 | |
| 0.204 | 0.045 | 0.204 | Cholinergic | 0.176 0.058 DB15534 | ||
| 0.172 | 0.028 | 0.229 | Expectorant | 0.143 0.038 DBMET02756 0.164 0.03 DBMET02757 0.229 0.015 DB15534 | DB15534 | |
| 0.208 | 0.065 | 0.224 | Non-steroidal antiinflammatory agent | 0.208 0.065 DBMET02756 0.199 0.072 DBMET02757 0.224 0.055 DB15534 | DB15534 | |
| 0.153 | 0.011 | 0.153 | Glutamate (mGluR7) agonist | 0.115 0.036 DB15534 | ||
| 0.196 | 0.056 | 0.196 | Tumour necrosis factor antagonist | 0.173 0.073 DB15534 | ||
| 0.151 | 0.016 | 0.151 | Acetylcholine release stimulant | 0.134 0.03 DBMET02756 0.132 0.032 DBMET02757 0.117 0.053 DB15534 | ||
| 0.23 | 0.095 | 0.38 | Antioxidant | 0.379 0.039 DBMET02756 0.38 0.039 DBMET02757 0.354 0.045 DB15534 | DBMET02757 | |
| 0.227 | 0.094 | 0.28 | Tyrosine 3 hydroxylase inhibitor | 0.265 0.055 DBMET02756 0.28 0.044 DBMET02757 0.275 0.048 DB15534 | DBMET02757 | |
| 0.141 | 0.009 | 0.141 | Glycine receptor antagonist | 0.083 0.052 DBMET02756 0.079 0.058 DBMET02757 0.135 0.011 DB15534 | ||
| 0.213 | 0.083 | 0.279 | RNA-directed DNA polymerase inhibitor | 0.279 0.037 DBMET02756 0.27 0.04 DBMET02757 0.246 0.052 DB15534 | DBMET02756 | |
| 0.167 | 0.046 | 0.167 | Alpha-N-acetylglucosaminidase inhibitor | 0.167 0.046 DB15534 | ||
| 0.123 | 0.009 | 0.136 | Neuraminidase inhibitor | 0.136 0.008 DB15534 | DB15534 | |
| 0.168 | 0.057 | 0.224 | NOS3 expression enhancer | 0.209 0.037 DBMET02756 0.203 0.04 DBMET02757 0.224 0.033 DB15534 | DB15534 | |
| 0.122 | 0.011 | 0.139 | Neuraminidase (influenza) inhibitor | 0.061 0.051 DBMET02756 0.139 0.009 DB15534 | DB15534 | |
| 0.199 | 0.098 | 0.36 | Free radical scavenger | 0.36 0.036 DBMET02756 0.351 0.039 DBMET02757 0.353 0.038 DB15534 | DBMET02756 | |
| 0.162 | 0.062 | 0.225 | Heat shock protein 90 antagonist | 0.135 0.091 DBMET02756 0.159 0.066 DBMET02757 0.225 0.028 DB15534 | DB15534 | |
| 0.185 | 0.086 | 0.322 | Amyloid beta aggregation inhibitor | 0.256 0.056 DBMET02756 0.262 0.054 DBMET02757 0.322 0.041 DB15534 | DB15534 | |
| 0.163 | 0.064 | 0.173 | Hexokinase inhibitor | 0.13 0.104 DBMET02756 0.173 0.055 DB15534 | DB15534 | |
| 0.146 | 0.049 | 0.161 | Alkylator | 0.136 0.055 DBMET02756 0.122 0.066 DBMET02757 0.161 0.041 DB15534 | DB15534 | |
| 0.25 | 0.155 | 0.345 | Histamine release inhibitor | 0.218 0.182 DBMET02756 0.306 0.12 DBMET02757 0.345 0.102 DB15534 | DB15534 | |
| 0.133 | 0.041 | 0.133 | Butyrylcholinesterase inhibitor | 0.116 0.049 DB15534 | ||
| 0.099 | 0.007 | 0.099 | 5 Hydroxytryptamine 7 agonist | 0.073 0.017 DB15534 | ||
| 0.15 | 0.06 | 0.174 | MAO inhibitor | 0.174 0.05 DB15534 | DB15534 | |
| 0.137 | 0.048 | 0.149 | Papain-like protease (SARS coronavirus) inhibitor | 0.119 0.083 DBMET02756 0.125 0.069 DBMET02757 0.149 0.035 DB15534 | DB15534 | |
| 0.151 | 0.068 | 0.227 | Lipid peroxidase inhibitor | 0.212 0.037 DBMET02756 0.204 0.04 DBMET02757 0.227 0.032 DB15534 | DB15534 | |
| 0.128 | 0.048 | 0.159 | Mucolytic | 0.11 0.065 DBMET02756 0.12 0.055 DBMET02757 0.159 0.028 DB15534 | DB15534 | |
| 0.147 | 0.069 | 0.147 | Neuropeptide Y1 antagonist | 0.128 0.105 DB15534 | ||
| 0.239 | 0.161 | 0.239 | Calcium channel activator | 0.214 0.193 DBMET02756 0.217 0.188 DBMET02757 | ||
| 0.168 | 0.091 | 0.205 | Hepatoprotectant | 0.192 0.07 DBMET02756 0.205 0.062 DBMET02757 0.202 0.063 DB15534 | DBMET02757 | |
| 0.129 | 0.052 | 0.13 | DNA intercalator | 0.105 0.069 DBMET02756 0.13 0.052 DB15534 | DB15534 | |
| 0.124 | 0.048 | 0.124 | Sphingosine 1-phosphate receptor 2 agonist | 0.101 0.098 DBMET02756 0.113 0.068 DB15534 | ||
| 0.136 | 0.061 | 0.146 | Cyclooxygenase 3 inhibitor | 0.146 0.052 DB15534 | DB15534 | |
| 0.102 | 0.027 | 0.139 | CDC25A inhibitor | 0.112 0.022 DBMET02756 0.139 0.014 DBMET02757 0.13 0.016 DB15534 | DBMET02757 | |
| 0.081 | 0.006 | 0.081 | Bradykinin B1 receptor antagonist | 0.034 0.014 DB15534 | ||
| 0.121 | 0.049 | 0.121 | Alpha 2c adrenoreceptor antagonist | 0.107 0.06 DB15534 | ||
| 0.234 | 0.163 | 0.266 | Immunosuppressant | 0.266 0.137 DB15534 | DB15534 | |
| 0.124 | 0.053 | 0.185 | Topoisomerase I inhibitor | 0.185 0.03 DBMET02756 0.146 0.043 DBMET02757 0.161 0.037 DB15534 | DBMET02756 | |
| 0.182 | 0.115 | 0.535 | Aldehyde oxidase inhibitor | 0.391 0.048 DBMET02756 0.535 0.028 DBMET02757 0.328 0.06 DB15534 | DBMET02757 | |
| 0.093 | 0.027 | 0.093 | 5 Hydroxytryptamine 7 antagonist | 0.06 0.045 DB15534 | ||
| 0.072 | 0.006 | 0.073 | Neuraminidase (Influenza A) inhibitor | 0.051 0.023 DBMET02756 0.073 0.006 DB15534 | DB15534 | |
| 0.067 | 0.006 | 0.067 | Melatonin antagonist | 0.035 0.012 DB15534 | ||
| 0.078 | 0.019 | 0.078 | Potassium channel (Ca-activated) blocker | 0.057 0.048 DB15534 | ||
| 0.091 | 0.033 | 0.1 | Lipase inhibitor | 0.063 0.061 DBMET02756 0.1 0.027 DB15534 | DB15534 | |
| 0.061 | 0.007 | 0.061 | Melatonin agonist | 0.029 0.028 DBMET02756 0.044 0.012 DB15534 | ||
| 0.057 | 0.003 | 0.057 | Melatonin receptor 1A antagonist | 0.015 0.008 DB15534 | ||
| 0.11 | 0.058 | 0.138 | MAO A inhibitor | 0.138 0.045 DB15534 | DB15534 | |
| 0.06 | 0.008 | 0.06 | Melatonin 2 agonist | 0.038 0.017 DBMET02756 0.038 0.017 DBMET02757 0.049 0.011 DB15534 | ||
| 0.212 | 0.163 | 0.242 | Antithrombotic | 0.206 0.171 DBMET02756 0.211 0.164 DBMET02757 0.242 0.133 DB15534 | DB15534 | |
| 0.057 | 0.008 | 0.057 | Melatonin 1 agonist | 0.03 0.029 DBMET02756 0.043 0.013 DB15534 | ||
| 0.096 | 0.05 | 0.128 | Antineoplastic alkaloid | 0.097 0.049 DBMET02756 0.113 0.041 DBMET02757 0.128 0.034 DB15534 | DB15534 | |
| 0.145 | 0.099 | 0.201 | Nitric oxide antagonist | 0.192 0.07 DBMET02756 0.201 0.067 DBMET02757 0.194 0.07 DB15534 | DBMET02757 | |
| 0.174 | 0.128 | 0.216 | Vasodilator | 0.155 0.15 DBMET02757 0.216 0.092 DB15534 | DB15534 | |
| 0.109 | 0.066 | 0.185 | Chelator | 0.172 0.03 DBMET02756 0.163 0.032 DBMET02757 0.185 0.027 DB15534 | DB15534 | |
| 0.046 | 0.005 | 0.046 | Melatonin 1 antagonist | 0.022 0.01 DB15534 | ||
| 0.153 | 0.114 | 0.153 | Psychostimulant | 0.147 0.119 DB15534 | ||
| 0.175 | 0.137 | 0.215 | Peptidyltransferase inhibitor | 0.173 0.141 DBMET02757 0.215 0.081 DB15534 | DB15534 | |
| 0.052 | 0.014 | 0.052 | Bradykinin antagonist | |||
| 0.106 | 0.068 | 0.108 | Multidrug resistance-associated protein 1 inhibitor | 0.108 0.065 DB15534 | DB15534 | |
| 0.056 | 0.02 | 0.056 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.105 | 0.071 | 0.106 | Electron transport complex I inhibitor | 0.106 0.07 DBMET02757 0.105 0.072 DB15534 | DBMET02757 | |
| 0.195 | 0.161 | 0.224 | 5 Hydroxytryptamine uptake stimulant | 0.212 0.13 DBMET02756 0.224 0.111 DBMET02757 0.214 0.127 DB15534 | DBMET02757 | |
| 0.087 | 0.054 | 0.087 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.23 | 0.197 | 0.315 | Antibacterial | 0.244 0.182 DBMET02756 0.223 0.203 DBMET02757 0.315 0.124 DB15534 | DB15534 | |
| 0.051 | 0.019 | 0.051 | Baculoviral IAP repeat-containing protein inhibitor | 0.047 0.028 DB15534 | ||
| 0.054 | 0.024 | 0.077 | Dopamine D2 agonist | 0.049 0.028 DBMET02756 0.064 0.019 DBMET02757 0.077 0.015 DB15534 | DB15534 | |
| 0.168 | 0.141 | 0.209 | Immunostimulant | 0.209 0.115 DB15534 | DB15534 | |
| 0.065 | 0.043 | 0.082 | CDC25B inhibitor | 0.071 0.037 DBMET02756 0.082 0.026 DBMET02757 0.082 0.026 DB15534 | DB15534 | |
| 0.061 | 0.039 | 0.093 | Heat shock protein 90 beta antagonist | 0.054 0.052 DBMET02756 0.069 0.029 DBMET02757 0.093 0.013 DB15534 | DB15534 | |
| 0.056 | 0.034 | 0.065 | DNA helicase inhibitor | 0.065 0.022 DBMET02756 0.059 0.03 DB15534 | DBMET02756 | |
| 0.14 | 0.121 | 0.166 | Lipocortins synthesis antagonist | 0.166 0.085 DBMET02756 0.158 0.094 DBMET02757 0.144 0.115 DB15534 | DBMET02756 | |
| 0.073 | 0.054 | 0.08 | Alpha 2a adrenoreceptor antagonist | 0.08 0.049 DB15534 | DB15534 | |
| 0.137 | 0.12 | 0.188 | DNA methyltransferase I inhibitor | 0.182 0.079 DBMET02756 0.149 0.105 DBMET02757 0.188 0.075 DB15534 | DB15534 | |
| 0.063 | 0.047 | 0.08 | Beta 3 adrenoreceptor antagonist | 0.061 0.052 DBMET02757 0.08 0.023 DB15534 | DB15534 | |
| 0.07 | 0.055 | 0.07 | Phosphodiesterase 4D inhibitor | |||
| 0.035 | 0.02 | 0.035 | Melatonin receptor 1A agonist | |||
| 0.048 | 0.035 | 0.067 | Carbonic anhydrase XIV inhibitor | 0.067 0.021 DB15534 | DB15534 | |
| 0.027 | 0.016 | 0.027 | Toll-Like receptor 4 agonist | 0.026 0.021 DB15534 | ||
| 0.06 | 0.05 | 0.061 | Dopamine D2 antagonist | 0.061 0.049 DB15534 | DB15534 | |
| 0.2 | 0.19 | 0.225 | Interleukin 2 agonist | 0.225 0.149 DB15534 | DB15534 | |
| 0.084 | 0.074 | 0.107 | Prolactin inhibitor | 0.093 0.063 DBMET02756 0.098 0.057 DBMET02757 0.107 0.049 DB15534 | DB15534 | |
| 0.09 | 0.08 | 0.09 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.084 | 0.077 | 0.099 | Protein kinase C zeta inhibitor | 0.098 0.053 DBMET02756 0.095 0.058 DBMET02757 0.099 0.051 DB15534 | DB15534 | |
| 0.043 | 0.038 | 0.043 | Potassium channel Kv1.3 blocker | |||
| 0.139 | 0.134 | 0.178 | Succinate dehydrogenase inhibitor | 0.173 0.077 DBMET02756 0.178 0.069 DBMET02757 0.163 0.09 DB15534 | DBMET02757 | |
| 0.082 | 0.077 | 0.087 | Breast cancer-resistant protein inhibitor | 0.081 0.079 DBMET02757 0.087 0.07 DB15534 | DB15534 | |
| 0.078 | 0.074 | 0.078 | T cell inhibitor | |||
| 0.063 | 0.06 | 0.064 | Dopamine antagonist | 0.064 0.059 DB15534 | DB15534 | |
| 0.011 | 0.01 | 0.011 | Melatonin 2 antagonist | |||
| 0.075 | 0.074 | 0.075 | Alpha 2 adrenoreceptor antagonist | |||
| 0.173 | 0.173 | 0.281 | Lipoxygenase inhibitor | 0.268 0.088 DBMET02756 0.275 0.084 DBMET02757 0.281 0.081 DB15534 | DB15534 | |
| 0.19 | 0.192 | 0.223 | Vasodilator, coronary | 0.223 0.161 DBMET02757 0.212 0.171 DB15534 | DBMET02757 | |
| 0.124 | 0.126 | 0.169 | Melanin inhibitor | 0.169 0.06 DBMET02756 0.169 0.06 DBMET02757 0.159 0.071 DB15534 | DBMET02757 | |
| 0.054 | 0.058 | 0.088 | Dopamine agonist | 0.069 0.045 DBMET02757 0.088 0.032 DB15534 | DB15534 | |
| 0.149 | 0.154 | 0.176 | Cyclic AMP phosphodiesterase inhibitor | 0.176 0.115 DBMET02757 0.162 0.134 DB15534 | DBMET02757 | |
| 0.078 | 0.083 | 0.092 | ATPase (Vacuolar H+) inhibitor | 0.09 0.055 DBMET02756 0.092 0.053 DB15534 | DB15534 | |
| 0.058 | 0.065 | 0.062 | Elastase 1 inhibitor | 0.062 0.059 DB15534 | DB15534 | |
| 0.085 | 0.095 | 0.11 | AMP-activated protein kinase stimulant | 0.106 0.063 DBMET02756 0.098 0.073 DBMET02757 0.11 0.058 DB15534 | DB15534 | |
| 0.018 | 0.029 | 0.03 | Dopamine D1 agonist | 0.023 0.016 DBMET02756 0.03 0.009 DBMET02757 0.028 0.01 DB15534 | DBMET02757 | |
| 0.075 | 0.091 | 0.093 | Bronchodilator | 0.093 0.072 DB15534 | DB15534 | |
| 0.03 | 0.046 | 0.049 | Dopamine D5 agonist | 0.041 0.027 DBMET02756 0.046 0.021 DBMET02757 0.049 0.018 DB15534 | DB15534 | |
| 0.049 | 0.067 | 0.076 | Dopamine D1 antagonist | 0.062 0.048 DBMET02756 0.075 0.036 DBMET02757 0.076 0.035 DB15534 | DB15534 | |
| 0.126 | 0.144 | 0.138 | Heat shock protein 70 antagonist | 0.138 0.083 DBMET02757 0.138 0.083 DB15534 | DB15534 | |
| 0.084 | 0.103 | 0.1 | Toll-Like receptor 4 antagonist | 0.1 0.07 DB15534 | DB15534 | |
| 0.074 | 0.094 | 0.096 | Granulocyte macrophage colony stimulating factor agonist | 0.09 0.051 DBMET02756 0.096 0.041 DBMET02757 0.082 0.071 DB15534 | DBMET02757 | |
| 0.184 | 0.204 | 0.252 | Apoptosis antagonist | 0.206 0.171 DBMET02756 0.209 0.168 DBMET02757 0.252 0.126 DB15534 | DB15534 | |
| 0.155 | 0.175 | 0.179 | 5 Hydroxytryptamine release stimulant | 0.179 0.142 DBMET02756 | DBMET02756 | |
| 0.079 | 0.101 | 0.092 | Anabolic | 0.092 0.075 DBMET02756 | DBMET02756 | |
| 0.155 | 0.178 | 0.227 | Superoxide dismutase inhibitor | 0.205 0.112 DBMET02756 0.227 0.091 DBMET02757 0.203 0.114 DB15534 | DBMET02757 | |
| 0.113 | 0.136 | 0.165 | Arachidonic acid antagonist | 0.151 0.087 DBMET02756 0.165 0.071 DBMET02757 0.135 0.106 DB15534 | DBMET02757 | |
| 0.053 | 0.08 | 0.07 | Antineoplastic antibiotic | 0.07 0.065 DB15534 | DB15534 | |
| 0.042 | 0.068 | 0.046 | Factor III inhibitor | 0.046 0.045 DBMET02757 | DBMET02757 | |
| 0.113 | 0.141 | 0.157 | Heat shock protein 90 alpha antagonist | 0.157 0.08 DB15534 | DB15534 | |
| 0.113 | 0.141 | 0.149 | Adenylate cyclase stimulant | 0.127 0.109 DBMET02756 0.149 0.064 DBMET02757 0.141 0.079 DB15534 | DBMET02757 | |
| 0.121 | 0.152 | 0.17 | DNA methylase inhibitor | 0.167 0.103 DBMET02756 0.17 0.101 DB15534 | DB15534 | |
| 0.165 | 0.197 | 0.245 | Hypoxia-inducible factor 1 alpha inhibitor | 0.245 0.105 DBMET02756 0.24 0.11 DBMET02757 0.231 0.118 DB15534 | DBMET02756 | |
| 0.048 | 0.082 | 0.067 | Beta adrenoreceptor antagonist | 0.067 0.043 DB15534 | DB15534 | |
| 0.116 | 0.156 | 0.129 | CF transmembrane conductance regulator agonist | 0.129 0.121 DBMET02756 | DBMET02756 | |
| 0.085 | 0.126 | 0.109 | Photosensitizer | 0.109 0.073 DBMET02756 0.098 0.092 DBMET02757 | DBMET02756 | |
| 0.083 | 0.13 | 0.104 | Bone formation stimulant | 0.104 0.102 DB15534 | DB15534 | |
| 0.098 | 0.147 | 0.14 | Protein-tyrosine phosphatase inhibitor | 0.122 0.111 DBMET02756 0.129 0.102 DBMET02757 0.14 0.09 DB15534 | DB15534 | |
| 0.02 | 0.069 | 0.037 | Dopamine D5 antagonist | 0.037 0.035 DBMET02757 | DBMET02757 | |
| 0.069 | 0.12 | 0.099 | Carbonic anhydrase III inhibitor | 0.099 0.063 DB15534 | DB15534 | |
| 0.034 | 0.085 | 0.087 | HIV-1 integrase (Strand Transfer) inhibitor | 0.087 0.028 DBMET02756 0.077 0.032 DBMET02757 0.075 0.033 DB15534 | DBMET02756 | |
| 0.02 | 0.073 | 0.04 | Estradiol 17 beta-dehydrogenase inhibitor | 0.04 0.031 DBMET02757 0.038 0.033 DB15534 | DBMET02757 | |
| 0.04 | 0.093 | 0.093 | HIV-1 integrase (3'-Processing) inhibitor | 0.093 0.029 DBMET02756 0.082 0.033 DBMET02757 0.083 0.032 DB15534 | DBMET02756 | |
| 0.102 | 0.158 | 0.179 | Angiogenesis stimulant | 0.179 0.106 DB15534 | DB15534 | |
| 0.043 | 0.101 | 0.066 | Carbonic anhydrase XIII inhibitor | 0.066 0.062 DB15534 | DB15534 | |
| 0.123 | 0.184 | 0.189 | Neurotrophic factor enhancer | 0.171 0.109 DBMET02756 0.189 0.088 DBMET02757 0.172 0.108 DB15534 | DBMET02757 | |
| 0.054 | 0.115 | 0.076 | Carbonic anhydrase VI inhibitor | 0.076 0.062 DB15534 | DB15534 | |
| 0.033 | 0.094 | 0.049 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.049 0.045 DBMET02756 | DBMET02756 | |
| 0.057 | 0.121 | 0.121 | 5-Lipoxygenase inhibitor | 0.108 0.058 DBMET02756 0.121 0.05 DBMET02757 0.111 0.056 DB15534 | DBMET02757 | |
| 0.044 | 0.11 | 0.067 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.067 0.065 DBMET02757 | DBMET02757 | |
| 0.016 | 0.084 | 0.041 | Catechol O-methyltransferase inhibitor | 0.032 0.023 DBMET02756 0.041 0.013 DBMET02757 0.037 0.017 DB15534 | DBMET02757 | |
| 0.145 | 0.216 | 0.244 | 12-Lipoxygenase inhibitor | 0.232 0.121 DBMET02756 0.224 0.127 DBMET02757 0.244 0.112 DB15534 | DB15534 | |
| 0.17 | 0.246 | 0.297 | 15-Lipoxygenase inhibitor | 0.222 0.189 DBMET02756 0.297 0.134 DB15534 | DB15534 | |
| 0.051 | 0.131 | 0.076 | Keratolytic | 0.074 0.058 DBMET02756 0.076 0.054 DBMET02757 | DBMET02757 | |
| 0.035 | 0.118 | 0.05 | Vanilloid 2 antagonist | 0.048 0.047 DBMET02757 0.05 0.042 DB15534 | DB15534 | |
| 0.061 | 0.152 | 0.105 | Estrogen receptor beta antagonist | 0.105 0.055 DBMET02756 0.102 0.06 DBMET02757 0.101 0.062 DB15534 | DBMET02756 | |
| 0.16 | 0.254 | 0.276 | Alpha-glucosidase inhibitor | 0.276 0.172 DB15534 | DB15534 | |
| 0.072 | 0.178 | 0.115 | Estrogen antagonist | 0.115 0.065 DBMET02756 0.112 0.071 DBMET02757 0.11 0.074 DB15534 | DBMET02756 | |
| 0.093 | 0.202 | 0.133 | Dual specificity phosphatase inhibitor | 0.133 0.116 DB15534 | DB15534 | |
| 0.066 | 0.184 | 0.123 | DOPA decarboxylase inhibitor | 0.123 0.041 DBMET02756 0.115 0.051 DBMET02757 | DBMET02756 | |
| 0.04 | 0.16 | 0.087 | Monophenol monooxygenase inhibitor | 0.087 0.085 DBMET02756 0.087 0.086 DB15534 | DB15534 | |
| 0.053 | 0.176 | 0.152 | Cystathionine beta-synthase inhibitor | 0.152 0.04 DBMET02756 0.132 0.05 DBMET02757 0.091 0.088 DB15534 | DBMET02756 | |
| 0.104 | 0.259 | 0.139 | Death-associated protein kinase 2 inhibitor | 0.139 0.134 DB15534 | DB15534 | |
| 0.045 | 0.206 | 0.099 | Cholesterol synthesis inhibitor | 0.099 0.089 DBMET02757 | DBMET02757 | |
| 0.05 | 0.211 | 0.135 | DNA polymerase I inhibitor | 0.135 0.058 DBMET02756 0.101 0.085 DBMET02757 | DBMET02756 | |
| 0.127 | 0.302 | 0.167 | Nitric-oxide synthase stimulant | 0.167 0.16 DBMET02756 | DBMET02756 | |
| 0.07 | 0.255 | 0.12 | Mannose-6-phosphate isomerase inhibitor | 0.12 0.101 DBMET02756 0.116 0.108 DBMET02757 | DBMET02756 | |
| 0.037 | 0.234 | 0.087 | Creatine kinase inhibitor | 0.087 0.076 DBMET02757 | DBMET02757 | |
| 0.172 | 0.377 | 0.27 | Antiinflammatory | 0.27 0.245 DB15534 | DB15534 | |
| 0.056 | 0.272 | 0.116 | Peroxidase inhibitor | 0.116 0.105 DBMET02756 | DBMET02756 | |
| 0.056 | 0.276 | 0.107 | Interleukin 4 antagonist | 0.107 0.106 DB15534 | DB15534 | |
| 0.027 | 0.273 | 0.063 | HIV-1 integrase inhibitor | 0.063 0.061 DBMET02756 | DBMET02756 | |
| 0.02 | 0.333 | 0.103 | M18 aspartyl aminopeptidase inhibitor | 0.103 0.088 DB15534 | DB15534 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |